Insider trades
Jason P. Rhodes, Director of Dyne Therapeutics DYN, has filed 0 purchases and 98 sales on the open market. Over the past 12 months that comes to a net sale of $46.1M. The latest trade was on 06/29.
Jason P. Rhodes
Director
- Company
- Dyne Therapeutics DYN
- First filing
- 23/05/25
- Trades
- 115 trades
- Buys / sales
- 0 / 98
- 12-month net buying
- −$46.1M
- Last trade
- 06/29
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
DYN | Open-market sale10b5-1 plan | 06/26–06/29 | 06/30 | 504,695 sh6 trades | $21.23avg. | $10,712,549.82 | −34.1% |
DYN | Open-market sale10b5-1 plan | 06/23–06/25 | 06/26 | 267,760 sh9 trades | $21.09avg. | $5,646,496.8 | −19.9% |
DYN | Open-market sale10b5-1 plan | 05/04–05/06 | 05/06 | 106,723 sh12 trades | $18.14avg. | $1,936,341.42 | −8.6% |
DYN | Open-market sale10b5-1 plan | 04/28 | 04/30 | 227,337 sh8 trades | $18.38avg. | $4,178,516.06 | −16.4% |
DYN | Open-market sale10b5-1 plan | 04/23–04/27 | 04/27 | 384,549 sh12 trades | $18.47avg. | $7,101,119.51 | −24.2% |
DYN | Open-market sale10b5-1 plan | 04/20–04/22 | 04/22 | 834,302 sh16 trades | $19.75avg. | $16,477,387.75 | −39.4% |
DYN | Open-market sale | 24/11/14 | 24/11/18 | 782 sh4 trades | $33.10avg. | $25,884.2 | −0.1% |
DYN | Open-market sale10b5-1 plan | 24/03/01 | 24/03/05 | 46,534 sh2 trades | $30.05avg. | $1,398,346.7 | −5.2% |
DYN | Open-market sale10b5-1 plan | 24/02/26–24/02/28 | 24/02/28 | 807,838 sh18 trades | $24.30avg. | $19,626,902.97 | −48.3% |
DYN | Open-market sale10b5-1 plan | 24/02/21–24/02/23 | 24/02/23 | 500,789 sh6 trades | $22.64avg. | $11,339,780.44 | −35.2% |
DYN | Open-market sale10b5-1 plan | 24/02/15–24/02/20 | 24/02/20 | 510,152 sh5 trades | $23.26avg. | $11,867,292.26 | −7.0% |